Skip to main content
SpringerLink
Log in

Managing and Minimizing Risk of Device Failure

  • Chapter
  • First Online:
Neuraxial Therapeutics

  • 301 Accesses

Abstract

Intrathecal (IT) drug delivery systems are utilized in the management of patients with chronic pain in whom more conservative measures have been unsuccessful; however, these patients are at risk for sudden device failure. Risk factors for device failure differ depending on the implanted device. Device failure may lead to medication withdrawal or overdose. Patients should be educated to recognize their device’s error alarms and to report for device interrogation as soon as possible when an alarm is triggered. Practitioners must be aware of the risk factors for device failure. Withdrawal can be managed by continuation of IT therapy through an external catheter or conversion to another route of administration and device explant with or without reimplantation should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Flowonix Medical I. Practice brochure. wwwflowonixcom. Internet: Flowonix; 2016.

    Google Scholar 

  2. Medtronic I. SynchroMed II Implant Manual. http://www.neuromodulation.ch/sites/default/files/pictures/synchromed_II_implant_manuel.pdf.

  3. Medtronic I. Use of Unapproved Drugs with the SynchroMed Implantable Infusion Pump. https://www.medtronic.com/content/dam/medtronic-com/professional/documents/product-advisories/tdd/app-drug-summary.pdf?bypassIM=true.

  4. Medtronic I. SynchroMed Programmable Infusion Systems Clinical Reference Guide. http://www.neurosurgeryresident.net/Op.%20Operative%20Techniques/00.%20Catalogs,%20Brochures,%20Manuals/Medtronic/Medtronic%20%20Synchromed%20II%20(Baclofen%20pump).pdf.

  5. Medtronic I. 2014 Product performance report. http://www.medtronic.me/content/dam/medtronic-com/products/product-performance/ppr-reports/product-performance-report-2014.pdf.

  6. Hayek SM, Joseph PN, Mekhail NA. Pharmacology of intrathecally administered agents for treatment of spasticity and pain. Sem Pain Med. 2003;1:238–53.

    Article  Google Scholar 

  7. Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, et al. Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses). Neuromodulation. 2012;15(5):483–95; discussion 96.

    Article  PubMed  Google Scholar 

  8. Veizi IE, Hayek SM, Hanes M, Galica R, Katta S, Yaksh T. Primary hydromorphone-related intrathecal catheter tip granulomas. Is there a role for dose and concentration? Neuromodulation. 2016;19(7):760–9.

    Article  PubMed  Google Scholar 

  9. Penning JP, Yaksh TL. Interaction of intrathecal morphine with bupivacaine and lidocaine in the rat. Anesthesiology. 1992;77(6):1186–2000.

    Article  PubMed  Google Scholar 

  10. Parpaglioni R, Baldassini B, Barbati G, Celleno D. Adding sufentanil to levobupivacaine or ropivacaine intrathecal anaesthesia affects the minimum local anaesthetic dose required. Acta Anaesthesiol Scand. 2009;53(9):1214–20.

    Article  PubMed  Google Scholar 

  11. Ngan Kee WD, Khaw KS, Ng FF, Ng KK, So R, Lee A. Synergistic interaction between fentanyl and bupivacaine given intrathecally for labor analgesia. Anesthesiology. 2014;120:1126–36.

    Article  PubMed  Google Scholar 

  12. Veizi IE, Hayek SM, Narouze S, Pope JE, Mekhail N. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients. Pain Med. 2011;12(10):1481–9.

    Article  PubMed  Google Scholar 

  13. Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, et al. Polyanalgesic consensus conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012;15(5):436–64; discussion 64–6.

    Article  PubMed  Google Scholar 

  14. Deer T, Pope J, Hayek S, et al. The Polyanalgesic consensus conference (PACC) recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20(2):96–132. https://doi.org/10.1111/ner.12538. Epub 2017 Jan 2.

    Article  PubMed  Google Scholar 

  15. Galica R, Hayek SM, Veizi IE, Lawrence MM, Khalil AA, McEwan MT. Sudden intrathecal drug delivery device motor stalls: a case series. Regional Anesthes Pain Med. 2016;41(2):135–9.

    Article  Google Scholar 

  16. Medtronic I. Important Information on Potential MRI Effects. http://www.medtronic.me/content/dam/medtronic-com/professional/documents/product-advisories/tdd/synchromed_mri_new_info.pdf.

  17. Medtronic I. MRI Information for SynchroMed II Pump https://mriquestions.com/uploads/3/4/5/7/34572113/synchromed_ii_mri_m005186c_a_001_view.pdf.

  18. De Andres J, Villanueva V, Palmisani S, Cerda-Olmedo G, Lopez-Alarcon MD, Monsalve V, et al. The safety of magnetic resonance imaging in patients with programmable implanted intrathecal drug delivery systems: a 3-year prospective study. Anesthes Analges. 2011;112(5):1124–9.

    Article  Google Scholar 

  19. Kosturakis A, Gebhardt R. SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging. Pain Physician. 2012;15(6):475–7.

    PubMed  Google Scholar 

  20. Medtronic I. Battery Performance of the Model 8637 SynchroMed® II Implantable Drug Infusion Pumps. https://www.bfarm.de/SharedDocs/Kundeninfos/EN/01/2011/04254-11_kundeninfo_en.pdf?__blob=publicationFile&v=4.

  21. Medtronic I. SynchroMed® Implantable Infusion Pump Internal Shorting. https://www.medtronic.com/content/dam/medtronic-com/professional/documents/product-advisories/tdd/synch-ii-shorting-adv.pdf?bypassIM=true.

  22. Medtronic I. SynchroMed II Implantable Drug Infusion Pump Overinfusion https://www.medtronic.com/content/dam/medtronic-com/professional/documents/product-advisories/tdd/hcp_overinfusion_recommendatio.pdf?bypassIM=true.

  23. Flowonix Medical I. Prometra II Programmable Pump Manual. http://wwwflowonixcom/sites/default/files/PL-31790-00 - Prometra II Programmable Pump IFU (Flowonix - US Commercial)pdf2015.

    Google Scholar 

  24. Rauck R, Deer T, Rosen S, Padda G, Barsa J, Dunbar E, et al. Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra((R)) programmable pump. Neuromodulation. 2010;13(2):102–8.

    Article  PubMed  Google Scholar 

  25. Rosen SM, Bromberg TA, Padda G, Barsa J, Dunbar E, Dwarakanath G, et al. Intrathecal administration of Infumorph(R) vs compounded morphine for treatment of intractable pain using the Prometra(R) programmable pump. Pain Med. 2013;14(6):865–73.

    Article  PubMed  Google Scholar 

  26. Codman and Shurtleff I. Codman 3000 Brochure. https://interaoncology.com/content-library/Codman-3000-Pump-US//Codman-3000-Pump-IFU.pdf.

  27. MedStream Programmable Infusion Pump and Refill Kits by Codman and Shurtleff: Class 1 Recall—Drug Over Infusion [press release]. 2013. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm371988.htm. Accessed 23 Oct 2013.

  28. Shellock FG, Crivelli R, Venugopalan R. Programmable infusion pump and catheter: evaluation using 3-tesla magnetic resonance imaging. Neuromodulation. 2008;11(3):163–70.

    Article  PubMed  Google Scholar 

  29. Tricumed. Tricumed Siromedes Internet: Tricumed; 2016. http://www.tricumed.de/index.php?id=siromedes_neu&L=1.

  30. Tricumed. Tricumed IP1000V Internet: Tricumed; 2016. https://www.cardion.cz/file/1094/ip1000v.pdf.

  31. Tricumed. Tricumed IP2000V Internet: Tricumed; 2016. https://www.tricumed.de/products/ip-2000-v/?lang=en.

  32. Dvorak EM, McGuire JR, Nelson ME. Incidence and identification of intrathecal baclofen catheter malfunction. PM R. 2010;2(8):751–6.

    Article  PubMed  Google Scholar 

  33. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symp Manag. 2000;19(3):209–15.

    Article  Google Scholar 

  34. Fremondiere F, Saout V, Lacoeuille F, Ferrapie AL, Menei P, Couturier O, et al. Isotopic scintigraphy combined with computed tomography: a useful method for investigating inefficiency of intrathecal baclofen. J Rehabil Med. 2014;46(7):712–4.

    Article  PubMed  Google Scholar 

  35. Singla A, Stojanovic MP, Chen L, Mao J. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion. Anesthes Analges. 2007;105(6):1816–9, table of contents.

    Article  Google Scholar 

  36. Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome—a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol. 2004;4:6.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Physical Med Rehabil. 2002;83(6):735–41.

    Article  Google Scholar 

  38. Bellinger A, Siriwetchadarak R, Rosenquist R, Greenlee JD. Prevention of intrathecal baclofen withdrawal syndrome: successful use of a temporary intrathecal catheter. Regional Anesthes Pain Med. 2009;34(6):600–2.

    Article  Google Scholar 

  39. Ross JC, Cook AM, Stewart GL, Fahy BG. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care. 2011;14(1):103–8.

    Article  PubMed  Google Scholar 

  40. Greenberg MI, Hendrickson RG. Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement. J Toxicol Clin Toxicol. 2003;41(1):83–5.

    Article  PubMed  Google Scholar 

  41. Kroin JS, Bianchi GD, Penn RD. Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. J Neurosurg. 1993;79(4):544–9.

    Article  PubMed  Google Scholar 

  42. Ackland GL, Fox R. Low-dose propofol infusion for controlling acute hyperspasticity after withdrawal of intrathecal baclofen therapy. Anesthesiology. 2005;103(3):663–5.

    Article  PubMed  Google Scholar 

  43. Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesthes Analges. 1995;80(5):1054–6.

    Google Scholar 

  44. Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for intrathecal baclofen withdrawal. Arch Physical Med Rehabil. 2003;84(5):638–42.

    Article  Google Scholar 

  45. Saveika JA, Shelton JE. Cyproheptadine for pediatric intrathecal baclofen withdrawal: a case report. Am J Phys Med Rehabil. 2007;86(12):994–7.

    Article  PubMed  Google Scholar 

  46. Lee HM, Ruggoo V, Graudins A. Intrathecal clonidine pump failure causing acute withdrawal syndrome with ‘stress-induced’ cardiomyopathy. J Med Toxicol. 2016;12(1):134–8.

    Article  PubMed  Google Scholar 

  47. Maino P, Koetsier E, Perez RS. Fentanyl overdose caused by malfunction of SynchroMed II intrathecal pump: two case reports. Regional Anesthes Pain Med. 2014;39(5):434–7.

    Article  Google Scholar 

  48. Medtronic I. SynchroMed implantable infusion pump priming bolus. https://professional.medtronic.com/pt/neuro/idd/ind/product-advisories/SYNCH-BOLUS-JUNE-2013 - .V2vye1dhpg12013.

  49. Sgouros S, Charalambides C, Matsota P, Tsangaris I, Kostopanagiotou G. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose. Pediatr Neurosurg. 2010;46(1):62–5.

    Article  PubMed  Google Scholar 

  50. Perruchoud C, Bovy M, Rutschmann B, Durrer A, Buchser E. Silicone septum leakage at the origin of a drug overdose in a patient implanted with an intrathecal pump. Neuromodulation. 2013;16(5):467–3; discussion 9–70.

    Article  PubMed  Google Scholar 

  51. Dalton C, Keenan E, Stevenson V. A novel cause of intrathecal baclofen overdosage: lessons to be learnt. Clin Rehabil. 2008;22(2):188–90.

    Article  PubMed  Google Scholar 

  52. Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012;50(2):107–11.

    Article  PubMed  Google Scholar 

  53. Shirley KW, Kothare S, Piatt JH Jr, Adirim TA. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care. 2006;22(4):258–61.

    Article  PubMed  Google Scholar 

  54. Ruan X, Couch JP, Liu H, Shah RV, Wang F, Chiravuri S. Respiratory failure following delayed intrathecal morphine pump refill: a valuable, but costly lesson. Pain Physician. 2010;13(4):337–41.

    Article  PubMed  Google Scholar 

  55. Coyne PJ, Hansen LA, Laird J, Buster P, Smith TJ. Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose. J Pain Symp Manag. 2004;28(3):273–6.

    Article  Google Scholar 

  56. Yilmaz A, Sogut A, Kilinc M, Sogut AG. Successful treatment of intrathecal morphine overdose. Neurol India. 2003;51(3):410–1.

    PubMed  Google Scholar 

  57. Groudine SB, Cresanti-Daknis C, Lumb PD. Successful treatment of a massive intrathecal morphine overdose. Anesthesiology. 1995;82(1):292–5.

    Article  PubMed  Google Scholar 

  58. Sauter K, Kaufman HH, Bloomfield SM, Cline S, Banks D. Treatment of high-dose intrathecal morphine overdose. Case report. J Neurosurg. 1994;81(1):143–6.

    Article  PubMed  Google Scholar 

  59. Lyew MA, Mondy C, Eagle S, Chernich SE. Hemodynamic instability and delayed emergence from general anesthesia associated with inadvertent intrathecal baclofen overdose. Anesthesiology. 2003;98(1):265–8.

    Article  PubMed  Google Scholar 

  60. Perruchoud C, Bovy M, Durrer A, Rosato M, Rutschmann B, Mustaki JP, et al. Severe hypertension following accidental clonidine overdose during the refilling of an implanted intrathecal drug delivery system. Neuromodulation. 2012;15(1):31–4; discussion 4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mt. Pleasant, SC, USA

    Ryan Galica

  2. Division of Pain Management, Department of Anesthesiology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

    Bradford A. Jones

  3. Division of Pain Medicine, Department of Anesthesiology, University Hospitals Cleveland Medical Center, Department of Anesthesiology and Perioperative Medicine, Cleveland, OH, USA

    Salim Michel Hayek

Authors
  1. Ryan Galica
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradford A. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salim Michel Hayek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. (CTF-312), UC San Diego-Anesthesia Res Lab 081 (CTF-312), La Jolla, CA, USA

    Tony Yaksh

  2. University Hospital, Case Western Reserve University, Cleveland, OH, USA

    Salim Hayek

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Galica, R., Jones, B.A., Hayek, S.M. (2023). Managing and Minimizing Risk of Device Failure. In: Yaksh, T., Hayek, S. (eds) Neuraxial Therapeutics. Springer, Cham. https://doi.org/10.1007/978-3-031-39558-1_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-39558-1_43

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-39557-4

  • Online ISBN: 978-3-031-39558-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation